Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: Potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium

Endocrinology

Volumn 141, Issue 11, 2000, Pages 4072-4080

  Lopez Bermejo, A ^a   Buckway, C K ^a   Devi, G R ^a   Hwa, V ^a   Plymate, S R ^a   Oh, Y ^a   Rosenfeld, R G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; RETINOIC ACID; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GROWTH RATE; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTO ONCOGENE; SENESCENCE;

EID: 0033695791     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7783     Document Type: Article

References (46)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. The insulin-like growth factor-binding protein (IGFBP) superfamily
3. Protein and messenger ribonudeic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium
4. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
5. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate
6. Insulin-like growth factor-binding proteins (IGFBP)-4, -5 and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization
7. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
8. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlations with serum prostate-specific antigen
9. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4, and 5
10. Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2, -4, and -5
11. Identification and characterization of genes differentially expressed in meningiomas
12. Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells
13. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells
14. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells
15. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
16. Characterization of insulin-like growth factor binding protein-related protein 1 in prostate cells
17. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
18. The modular architecture of a new family of growth regulators related to connective tissue growth factor
19. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene
20. Proviral rearrangements and overexpression of a new cellular gene (NOV) in myeloblastosis-associated virus type 1-induced nephroblastomas
21. Structural analysis of the human NOV proto-oncogene and expression in Wilms tumor
22. The novH proto-oncogen mRNA is differentially expressed in human prostate cell lines: A new marker for tumor progression?
23. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen
24. Generation and characterization of an IGFBP-7 antibody: Identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media
25. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-β in Hs578T human breast cancer cells
26. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP super family
27. Synthesis and characterization of insulin-like growth factor binding protein-7 (IGFBP-7)
28. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily
29. The connective-tissue growth factor/cystein-rich 61/nephroblastoma overexpressed (CCN) family
30. Cellular senescence and cancer
31. p16/pRb pathway alterations are required for bypassing senescene in human prostate epithelial cells
32. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and -beta 3 by cultured human prostate cells
33. Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells
34. The insulin-like growth factor system in the prostate
35. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid
36. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer
37. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1
38. Minireview: The CCN family of angiogenic regulators: The integrin connection
39. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF)) mRNA
40. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors
41. Expression of fibrogenic cytokines in desmoplastic malignant melanoma
42. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells
43. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7
44. Transforming growth factor-beta in benign and malignant prostate
45. Abnormal level of retinoic acid in prostate cancer tissues
46. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation